{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "NCoV", "Pneumonia", "Prevention", "Treatment", "Vaccines"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34388532", "DateCompleted": {"Year": "2021", "Month": "09", "Day": "28"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "08", "Day": "05"}], "Language": ["eng"], "ELocationID": ["10.1016/j.biopha.2021.112015", "S0753-3322(21)00798-8"], "Journal": {"ISSN": "1950-6007", "JournalIssue": {"Volume": "142", "PubDate": {"Year": "2021", "Month": "Oct"}}, "Title": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie", "ISOAbbreviation": "Biomed Pharmacother"}, "ArticleTitle": "COVID-19 challenges and its therapeutics.", "Pagination": {"StartPage": "112015", "MedlinePgn": "112015"}, "Abstract": {"AbstractText": ["COVID-19, an infectious disease, has emerged as one of the leading causes of death worldwide, making it one of the severe public health issues in recent decades. nCoV, the novel SARS coronavirus that causes COVID-19, has brought together scientists in the quest for possible therapeutic and preventive measures. The development of new drugs to manage COVID-19 effectively is a challenging and time-consuming process, thus encouraging extensive investigation of drug repurposing and repositioning candidates. Several medications, including remdesivir, hydroxychloroquine, chloroquine, lopinavir, favipiravir, ribavirin, ritonavir, interferons, azithromycin, capivasertib and bevacizumab, are currently under clinical trials for COVID-19. In addition, several medicinal plants with considerable antiviral activities are potential therapeutic candidates for COVID-19. Statistical data show that the pandemic is yet to slow down, and authorities are placing their hopes on vaccines. Within a short period, four types of vaccines, namely, whole virus, viral vector, protein subunit, and nucleic acid (RNA/DNA), which can confer protection against COVID-19 in different ways, were already in a clinical trial. SARS-CoV-2 variants spread is associated with antibody escape from the virus Spike epitopes, which has grave concerns for viral re-infection and even compromises the effectiveness of the vaccines. Despite these efforts, COVID-19 treatment is still solely based on clinical management through supportive care. We aim to highlight the recent trends in COVID-19, relevant statistics, and clinical findings, as well as potential therapeutics, including in-line treatment methods, preventive measures, and vaccines to combat the prevalence of COVID-19."], "CopyrightInformation": "Copyright \u00a9 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Abasyn University Peshawar, Pakistan."}], "LastName": "Rehman", "ForeName": "Sabi Ur", "Initials": "SU"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Abasyn University Peshawar, Pakistan. Electronic address: shaheed.rehman@abasyn.edu.pk."}], "LastName": "Rehman", "ForeName": "Shaheed Ur", "Initials": "SU"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Republic of Korea. Electronic address: yoohh@hanyang.ac.kr."}], "LastName": "Yoo", "ForeName": "Hye Hyun", "Initials": "HH"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "France", "MedlineTA": "Biomed Pharmacother", "NlmUniqueID": "8213295", "ISSNLinking": "0753-3322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "COVID-19 Vaccines"}], "MeshHeadingList": [{"QualifierName": ["classification", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["classification", "complications", "prevention & control"], "DescriptorName": "COVID-19"}, {"QualifierName": ["classification", "pharmacology"], "DescriptorName": "COVID-19 Vaccines"}, {"QualifierName": ["methods"], "DescriptorName": "Drug Development"}, {"QualifierName": ["methods"], "DescriptorName": "Drug Discovery"}, {"QualifierName": ["methods"], "DescriptorName": "Drug Repositioning"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gralinski L.E., Menachery V.D. Return of the coronavirus: 2019-nCoV. Viruses. 2020;12(2):135.", "ArticleIdList": ["PMC7077245", "31991541"]}, {"Citation": "Li F. Structure, function, and evolution of coronavirus spike proteins. Annu. Rev. Virol. 2016;3:237\u2013261.", "ArticleIdList": ["PMC5457962", "27578435"]}, {"Citation": "Weiss S.R., Leibowitz J.L. Coronavirus pathogenesis. Adv. Virus Res. 2011;81:85\u2013164.", "ArticleIdList": ["PMC7149603", "22094080"]}, {"Citation": "Tang Q., Song Y., Shi M., Cheng Y., Zhang W., Xia X.-Q. Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition. Sci. Rep. 2015;5:17155.", "ArticleIdList": ["PMC4660426", "26607834"]}, {"Citation": "Comber L., Walsh K.A., Jordan K., O\u2019Brien K.K., Clyne B., Teljeur C., Drummond L., Carty P.G., De Gascun C.F., Smith S.M. Alternative clinical specimens for the detection of SARS-CoV-2: a rapid review. Rev. Med. Virol. 2021;31:2185.", "ArticleIdList": ["33091200"]}, {"Citation": "Song Z., Xu Y., Bao L., Zhang L., Yu P., Qu Y., Zhu H., Zhao W., Han Y., Qin C. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019;11(1):59.", "ArticleIdList": ["PMC6357155", "30646565"]}, {"Citation": "Almutairi K.M., Al Helih E.M., Moussa M., Boshaiqah A.E., Saleh Alajilan A., Vinluan J.M., Almutairi A. Awareness, attitudes, and practices related to coronavirus pandemic among public in Saudi Arabia. Fam. Community Health. 2015;38(4):332\u2013340.", "ArticleIdList": ["26291193"]}, {"Citation": "Lai C.C., Shih T.-P., Ko W.-C., Tang H.-J., Hsueh P.-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Int. J. Antimicrob. Agents. 2020;55", "ArticleIdList": ["PMC7127800", "32081636"]}, {"Citation": "Cui J., Li F., Shi Z.-L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17(3):181\u2013192.", "ArticleIdList": ["PMC7097006", "30531947"]}, {"Citation": "Banerjee A., Kulcsar K., Misra V., Frieman M., Mossman K. Bats and coronaviruses. Viruses. 2019;11(1):41.", "ArticleIdList": ["PMC6356540", "30634396"]}, {"Citation": "Wang N., Li S.-Y., Yang X.-L., Huang H.-M., Zhang Y.-J., Guo H., Luo C.-M., Miller M., Zhu G., Chmura A.A. Serological evidence of bat SARS-related coronavirus infection in humans, China. Virol. Sin. 2018;33(1):104\u2013107.", "ArticleIdList": ["PMC6178078", "29500691"]}, {"Citation": "Guan Y., Zheng B., He Y., Liu X., Zhuang Z., Cheung C., Luo S., Li P., Zhang L., Guan Y. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302(5643):276\u2013278.", "ArticleIdList": ["12958366"]}, {"Citation": "Azhar E.I., El-Kafrawy S.A., Farraj S.A., Hassan A.M., Al-Saeed M.S., Hashem A.M., Madani T.A. Evidence for camel-to-human transmission of MERS coronavirus. New Engl. J. Med. 2014;370(26):2499\u20132505.", "ArticleIdList": ["24896817"]}, {"Citation": "Sabir J.S., Lam T.T.-Y., Ahmed M.M., Li L., Shen Y., Abo-Aba S.E., Qureshi M.I., Abu-Zeid M., Zhang Y., Khiyami M.A. Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia. Science. 2016;351(6268):81\u201384.", "ArticleIdList": ["26678874"]}, {"Citation": "Zhu Z., Zhang Z., Chen W., Cai Z., Ge X., Zhu H., Jiang T., Tan W., Peng Y. Predicting the receptor-binding domain usage of the coronavirus based on kmer frequency on spike protein. Infect. Genet. Evol. 2018;61:183\u2013184.", "ArticleIdList": ["PMC7129160", "29625240"]}, {"Citation": "Ge X.-Y., Li J.-L., Yang X.-L., Chmura A.A., Zhu G., Epstein J.H., Mazet J.K., Hu B., Zhang W., Peng C. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature. 2013;503(7477):535\u2013538.", "ArticleIdList": ["PMC5389864", "24172901"]}, {"Citation": "Wu A., Peng Y., Huang B., Ding X., Wang X., Niu P., Meng J., Zhu Z., Zhang Z., Wang J. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27(3):325\u2013328.", "ArticleIdList": ["PMC7154514", "32035028"]}, {"Citation": "Chan J.F.-W., Yuan S., Kok K.-H., To K.K.-W., Chu H., Yang J., Xing F., Liu J., Yip C.C.-Y., Poon R.W.-S. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514\u2013523.", "ArticleIdList": ["PMC7159286", "31986261"]}, {"Citation": "Peiris J., Yuen K., Osterhaus A., Stohr K. The severe acute respiratory syndrome. New Engl. J. Med. 2003;349:2431\u20132441.", "ArticleIdList": ["14681510"]}, {"Citation": "Wang Y., Dong C., Li C., Zhang X., Ren Q., Shi H., Hu Y., Zhou M. Temporal changes of CT findings in 90 patients with COVID-19 pneumonia: a longitudinal study. Radiology. 2020;296(2):E55\u2013E64.", "ArticleIdList": ["PMC7233482", "32191587"]}, {"Citation": "Heymann D.L., Shindo N. COVID-19: what is next for public health? Lancet. 2020;395(10224):542\u2013545.", "ArticleIdList": ["PMC7138015", "32061313"]}, {"Citation": "Surveillances Vital. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) China CDC Wkly. 2020;2(8):113\u2013122.", "ArticleIdList": ["PMC8392929", "34594836"]}, {"Citation": "Yang X., Yu Y., Xu J., Shu H., Liu H., Wu Y., Zhang L., Yu Z., Fang M., Yu T. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 2020;8(5):475\u2013481.", "ArticleIdList": ["PMC7102538", "32105632"]}, {"Citation": "Yang J., Zheng Y., Gou X., Pu K., Chen Z., Guo Q., Ji R., Wang H., Wang Y., Zhou Y. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int. J. Infect. Dis. 2020;94:91\u201395.", "ArticleIdList": ["PMC7194638", "32173574"]}, {"Citation": "World Health Organization (WHO), Coronavirus (COVID-19) Dashboard. Centers for Retrieved at June 19, 2021, https://covid19.who.int/."}, {"Citation": "Ghinai I., McPherson T.D., Hunter J.C., Kirking H.L., Christiansen D., Joshi K., Rubin R., Morales-Estrada S., Black S.R., Pacilli M. First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA. Lancet. 2020;395(10230):1137\u20131144.", "ArticleIdList": ["PMC7158585", "32178768"]}, {"Citation": "N.P. O'Grady M. Alexander E.P. Dellinger J.L. Gerberding S.O. Heard D.G. Maki H. Masur R.D. McCormick L.A. Mermel M.L. Pearson. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention, MMWR. Recommendations and reports: Morbidity and mortality weekly report Recomm. Rep. 51 RR-10 2002 1 29.", "ArticleIdList": ["12233868"]}, {"Citation": "Cascella M., Rajnik M., Aleem A., Dulebohn S., Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19) StatPearls. 2021 \u3008https://www.statpearls.com/ArticleLibrary/viewarticle/52171\u3009", "ArticleIdList": ["32150360"]}, {"Citation": "Rothe C., Schunk M., Sothmann P., Bretzel G., Froeschl G., Wallrauch C., Zimmer T., Thiel V., Janke C., Guggemos W. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New Engl. J. Med. 2020;382(10):970\u2013971.", "ArticleIdList": ["PMC7120970", "32003551"]}, {"Citation": "Kupferschmidt K. Study claiming new coronavirus can be transmitted by people without symptoms was flawed. Science. 2020;3(10.1126)"}, {"Citation": "Yu P., Zhu J., Zhang Z., Han Y., Huang L. A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period. J. Infect. Dis. 2020;221(11):1757\u20131761.", "ArticleIdList": ["PMC7107453", "32067043"]}, {"Citation": "Bai Y., Yao L., Wei T., Tian F., Jin D.-Y., Chen L., Wang M. Presumed asymptomatic carrier transmission of COVID-19. Jama. 2020;323(14):1406\u20131407.", "ArticleIdList": ["PMC7042844", "32083643"]}, {"Citation": "Hu Z., Song C., Xu C., Jin G., Chen Y., Xu X., Ma H., Chen W., Lin Y., Zheng Y. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci. China Life Sci. 2020;63:706\u2013711.", "ArticleIdList": ["PMC7088568", "32146694"]}, {"Citation": "Lai C.C., Liu Y.H., Wang C.-Y., Wang Y.-H., Hsueh S.-C., Yen M.-Y., Ko W.-C., Hsueh P.-R. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): facts and myths. J. Microbiol. Immunol. Infect. 2020;53(3):404\u2013412.", "ArticleIdList": ["PMC7128959", "32173241"]}, {"Citation": "Li Z., Yi Y., Luo X., Xiong N., Liu Y., Li S., Sun R., Wang Y., Hu B., Chen W. Development and clinical application of a rapid IgM\u2010IgG combined antibody test for SARS\u2010CoV\u20102 infection diagnosis. J. Med. Virol. 2020;92(9):1518\u20131524.", "ArticleIdList": ["PMC7228300", "32104917"]}, {"Citation": "Kamangu C., Dellit T., Lynch J., Novel P., Sekizuka T., Katoh H., Kato F., Sakata M., Tahara M., Kutsuna S., 1: Wang C., Liu Z., Chen Z., Huang X., Xu M., He T., Zhang Z. The establishment of reference sequence for SARS-CoV-2 and variation analysis. J. Med. Virol. 2020;92(6):667\u2013674.", "ArticleIdList": ["PMC7228400", "32167180"]}, {"Citation": "Planas D., Veyer D., Baidaliuk A., Staropoli I., Guivel-Benhassine F., Rajah M.M., Planchais C., Porrot F., Robillard N., Puech J. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature. 2021:1\u20137. doi: 10.1038/s41586-021-03777-9.", "ArticleIdList": ["10.1038/s41586-021-03777-9", "34237773"]}, {"Citation": "Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., Ren R., Leung K.S., Lau E.H., Wong J.Y. Early transmission dynamics in Wuhan, China, of novel coronavirus\u2013infected pneumonia. New Engl. J. Med. 2020;382:1199\u20131207.", "ArticleIdList": ["PMC7121484", "31995857"]}, {"Citation": "Guan W.-j, Ni Z.-y, Hu Y., Liang W.-h, Ou C.-q, He J.-x, Liu L., Shan H., Lei C.-l, Hui D.S. Clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv. 2020 doi: 10.1101/2020.02.06.20020974.", "ArticleIdList": ["10.1101/2020.02.06.20020974"]}, {"Citation": "Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.", "ArticleIdList": ["PMC7159299", "31986264"]}, {"Citation": "Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u2013513.", "ArticleIdList": ["PMC7135076", "32007143"]}, {"Citation": "Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061\u20131069.", "ArticleIdList": ["PMC7042881", "32031570"]}, {"Citation": "Liu J., Liu Y., Xiang P., Pu L., Xiong H., Li C., Zhang M., Tan J., Xu Y., Song R. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J. Transl. Med. 2020;18:1\u201312.", "ArticleIdList": ["PMC7237880", "32434518"]}, {"Citation": "Zhang J.J., Dong X., Cao Y.Y., Yuan Yd, Yang Yb, Yan Yq, Akdis C.A., Gao Yd. Clinical characteristics of 140 patients infected by SARS\u2010CoV\u20102 in Wuhan, China. Allergy. 2020;75(7):1730\u20131741.", "ArticleIdList": ["32077115"]}, {"Citation": "Zu Z.Y., Jiang M.D., Xu P.P., Chen W., Ni Q.Q., Lu G.M., Zhang L.J. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology. 2020;296(2):E15\u2013E25.", "ArticleIdList": ["PMC7233368", "32083985"]}, {"Citation": "Centers for Disease Control and Prevention (CDC), Symptoms of COVID-19. Retrieved at June 19, 2021, from web page: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html."}, {"Citation": "Bernheim A., Mei X., Huang M., Yang Y., Fayad Z.A., Zhang N., Diao K., Lin B., Zhu X., Li K. Chest CT findings in coronavirus disease-19 (COVID-19): Relationship to duration of infection. Radiology. 2020;95:685\u2013691.", "ArticleIdList": ["PMC7233369", "32077789"]}, {"Citation": "Ai T., Yang Z., Hou H., Zhan C., Chen C., Lv W., Tao Q., Sun Z., Xia L. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020;296:E32\u2013E40.", "ArticleIdList": ["PMC7233399", "32101510"]}, {"Citation": "Yang W., Cao Q., Qin L., Wang X., Cheng Z., Pan A., Dai J., Sun Q., Zhao F., Qu J. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China. J. Infect. 2020;80(4):388\u2013393.", "ArticleIdList": ["PMC7102539", "32112884"]}, {"Citation": "Shi H., Han X., Jiang N., Cao Y., Alwalid O., Gu J., Fan Y., Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect. Dis. 2020;20:425\u2013434.", "ArticleIdList": ["PMC7159053", "32105637"]}, {"Citation": "Mizumoto K., Chowell G. Estimating the risk of 2019 Novel Coronavirus death during the course of the outbreak in China, 2020. medRxiv. 2020 doi: 10.1101/2020.02.19.20025163.", "ArticleIdList": ["10.1101/2020.02.19.20025163"]}, {"Citation": "Zhang G., Hu C., Luo L., Fang F., Chen Y., Li J., Peng Z., Pan H. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J. Clin. Virol. 2020;127", "ArticleIdList": ["PMC7194884", "32311650"]}, {"Citation": "Centers for Disease Control and Prevention (CDC). How to Protect Yourself & Others. Retrieved at July 19, 2021, from web page: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html."}, {"Citation": "Li G., Fan Y., Lai Y., Han T., Li Z., Zhou P., Pan P., Wang W., Hu D., Liu X. Coronavirus infections and immune responses. J. Med. Virol. 2020;92(4):424\u2013432.", "ArticleIdList": ["PMC7166547", "31981224"]}, {"Citation": "Zumla A., Hui D.S., Azhar E.I., Memish Z.A., Maeurer M. Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet. 2020;395(10224):e35\u2013e36.", "ArticleIdList": ["PMC7133595", "32035018"]}, {"Citation": "World Health Organization (WHO). Weekly Epidemiological and Operational Updates Retrieved July 19 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports."}, {"Citation": "Chen Z.M., Fu J.-F., Shu Q., Chen Y.-H., Hua C.-Z., Li F.-B., Lin R., Tang L.-F., Wang T.-L., Wang W. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J. Clin. Pediatr. 2020;16(3):240\u2013246.", "ArticleIdList": ["PMC7091166", "32026148"]}, {"Citation": "Shen K., Yang Y., Wang T., Zhao D., Jiang Y., Jin R., Zheng Y., Xu B., Xie Z., Lin L. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts\u2019 consensus statement. World J. Clin. Pediatr. 2020;16(3):223\u2013231.", "ArticleIdList": ["PMC7090771", "32034659"]}, {"Citation": "Russell C.D., Millar J.E., Baillie J.K. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395(10223):473\u2013475.", "ArticleIdList": ["PMC7134694", "32043983"]}, {"Citation": "Zhao J., Hu Y., Du R., Chen Z., Jin Y., Zhou M., Zhang J., Qu J., Cao B. Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:007.", "ArticleIdList": ["32034899"]}, {"Citation": "NIH COVID-19 Treatment Guidelines Retrieved July 18 2021. https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/."}, {"Citation": "Arihiro S., Nakashima A., Matsuoka M., Suto S., Uchiyama K., Kato T., Mitobe J., Komoike N., Itagaki M., Miyakawa Y. Randomized trial of vitamin D supplementation to prevent seasonal influenza and upper respiratory infection in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 2019;25(6):1088\u20131095.", "ArticleIdList": ["PMC6499936", "30601999"]}, {"Citation": "G. Sciences. Gilead Sciences Statement on Phase 3 Veklury\u00ae (Remdesivir) Intravenous Study in High Risk Non-Hospitalized Patients with COVID-19 (Accessed 16 July 2021). https://www.gilead.com/news-and-press/company-statements/gilead-sciences-statement-on-phase-3-veklury-remdesivir-study-in-high-risk-non-hospitalized-patients-with-covid-19."}, {"Citation": "Wang M., Cao R., Zhang L., Yang X., Liu J., Xu M., Shi Z., Hu Z., Zhong W., Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269\u2013271.", "ArticleIdList": ["PMC7054408", "32020029"]}, {"Citation": "Sheahan T.P., Sims A.C., Graham R.L., Menachery V.D., Gralinski L.E., Case J.B., Leist S.R., Pyrc K., Feng J.Y., Trantcheva I. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci. Transl. Med. 2017;9(396) doi: 10.1126/scitranslmed.aal3653.", "ArticleIdList": ["10.1126/scitranslmed.aal3653", "PMC5567817", "28659436"]}, {"Citation": "Holshue M.L., DeBolt C., Lindquist S., Lofy K.H., Wiesman J., Bruce H., Spitters C., Ericson K., Wilkerson S., Tural A. First case of 2019 novel coronavirus in the United States. New Engl. J. Med. 2020;382(10):929\u2013936. doi: 10.1056/NEJMoa2001191.", "ArticleIdList": ["10.1056/NEJMoa2001191", "PMC7092802", "32004427"]}, {"Citation": "Yao X., Ye F., Zhang M., Cui C., Huang B., Niu P., Liu X., Zhao L., Dong E., Song C. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clin. Infect. Dis. 2020;71(15):732\u2013739.", "ArticleIdList": ["PMC7108130", "32150618"]}, {"Citation": "Colson P., Rolain J.-M., Lagier J.-C., Brouqui P., Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int. J. Antimicrob. Agents. 2020;55 doi: 10.1016/j.ijantimicag.2020.105932.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105932", "PMC7135139", "32145363"]}, {"Citation": "Cortegiani A., Ingoglia G., Ippolito M., Giarratano A., Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J. Crit. Care. 2020;57:279\u2013283.", "ArticleIdList": ["PMC7270792", "32173110"]}, {"Citation": "Drosten C., G\u00fcnther S., Preiser W., van der Werf S., Brodt H.R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R.A., Berger A.M., Burgui\u00e8re J., Cinatl M., Eickmann N., Escriou K., Grywna S., Kramme J.C., Manuguerra S., M\u00fcller V., Rickerts M., St\u00fcrmer S., Vieth H.D., Klenk A.D., Osterhaus H., Schmitz H.W., Doerr A. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 2003;348(20):1967\u20131976.", "ArticleIdList": ["12690091"]}, {"Citation": "Ferner R.E., Aronson J.K. Chloroquine and hydroxychloroquine in covid-19. BMJ Brit. Med. J. 2020;96:550\u2013555.", "ArticleIdList": ["32269046"]}, {"Citation": "Liu J., Cao R., Xu M., Wang X., Zhang H., Hu H., Li Y., Hu Z., Zhong W., Wang M. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020;6(1):1\u20134.", "ArticleIdList": ["PMC7078228", "32194981"]}, {"Citation": "Chen Y., Li M.-X., Lu G.-D., Shen H.-M., Zhou J. Hydroxychloroquine/chloroquine as therapeutics for COVID-19: truth under the mystery. Int. J. Biol. Sci. 2021;17:1538\u20131546.", "ArticleIdList": ["PMC8071775", "33907517"]}, {"Citation": "Gao J., Tian Z., Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci. Trends. 2020;14:72\u201373.", "ArticleIdList": ["32074550"]}, {"Citation": "Lv Z., Chu Y., Wang Y. HIV protease inhibitors: a review of molecular selectivity and toxicity. HIV AIDS. 2015:95.", "ArticleIdList": ["PMC4396582", "25897264"]}, {"Citation": "Yu B., Li C., Chen P., Zhou N., Wang L., Li J., Jiang H., Wang D.-W. Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19. Sci. China Life Sci. 2020;63:1515\u20131521.", "ArticleIdList": ["PMC7228868", "32418114"]}, {"Citation": "Hadjadj J., Yatim N., Barnabei L., Corneau A., Boussier J., Smith N., P\u00e9r\u00e9 H., Charbit B., Bondet V., Chenevier-Gobeaux C. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369(6504):718\u2013724.", "ArticleIdList": ["PMC7402632", "32661059"]}, {"Citation": "Miao G., Zhao H., Li Y., Ji M., Chen Y., Shi Y., Bi Y., Wang P., Zhang H. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation. Dev. Cell. 2021;56(4):427\u2013442.", "ArticleIdList": ["PMC7832235", "33422265"]}, {"Citation": "Parnham M.J., Haber V.E., Giamarellos-Bourboulis E.J., Perletti G., Verleden G.M., Vos R. Azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacol. Ther. 2014;143(2):225\u2013245.", "ArticleIdList": ["24631273"]}, {"Citation": "Kuo C.H., Lee M.-S., Kuo H.-F., Lin Y.-C., Hung C.-H. Azithromycin suppresses Th1-and Th2-related chemokines IP-10/MDC in human monocytic cell line. J. Microbiol. Immunol. Infect. 2019;52(6):872\u2013879.", "ArticleIdList": ["31759853"]}, {"Citation": "Sch\u00f6gler A., Kopf B.S., Edwards M.R., Johnston S.L., Casaulta C., Kieninger E., Jung A., Moeller A., Geiser T., Regamey N. Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells. Eur. Respir. J. 2015;45(2):428\u2013439.", "ArticleIdList": ["25359346"]}, {"Citation": "Deretic V., Timmins G.S. Azithromycin and ciprofloxacin have a chloroquine-like effect on respiratory epithelial cells. bioRxiv. 2020 doi: 10.1101/2020.03.29.008631.", "ArticleIdList": ["10.1101/2020.03.29.008631"]}, {"Citation": "Andreani J., Le Bideau M., Duflot I., Jardot P., Rolland C., Boxberger M., Wurtz N., Rolain J.-M., Colson P., La Scola B. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. Microb. Pathog. 2020;145", "ArticleIdList": ["PMC7182748", "32344177"]}, {"Citation": "Mitra R.L., Greenstein S.A., Epstein L.M. An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: possible benefits of intravenous lidocaine. Heart Case Rep. 2020;6(5):244\u2013248.", "ArticleIdList": ["PMC7195299", "32363145"]}, {"Citation": "G\u00e9rard A., Romani S., Fresse A., Viard D., Parassol N., Granvuillemin A., Chouchana L., Rocher F., Drici M.-D. \u201cOff-label\u201d use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: a survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers. Therapies. 2020;75(4):371\u2013379.", "ArticleIdList": ["PMC7204701", "32418730"]}, {"Citation": "Molina J.M., Delaugerre C., Le Goff J., Mela-Lima B., Ponscarme D., Goldwirt L., de Castro N. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. Med. Mal. Infect. 2020;50(4):384.", "ArticleIdList": ["PMC7195369", "32240719"]}, {"Citation": "Kawamura K., Ichikado K., Takaki M., Eguchi Y., Anan K., Suga M. Adjunctive therapy with azithromycin for moderate and severe acute respiratory distress syndrome: a retrospective, propensity score-matching analysis of prospectively collected data at a single center. Int. J. Antimicrob. Agents. 2018;51(6):918\u2013924.", "ArticleIdList": ["29501821"]}, {"Citation": "Gautret P., Lagier J.C., Parola P., Meddeb L., Mailhe M., Doudier B., Courjon J., Giordanengo V., Vieira V.E., Dupont H.T. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int. J. Antimicrob. Agents. 2020;56(1)", "ArticleIdList": ["PMC7102549", "32205204"]}, {"Citation": "Rosenberg E.S., Dufort E.M., Udo T., Wilberschied L.A., Kumar J., Tesoriero J., Weinberg P., Kirkwood J., Muse A., DeHovitz J. Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State. JAMA. 2020;323(24):2493\u20132502.", "ArticleIdList": ["PMC7215635", "32392282"]}, {"Citation": "Magagnoli J., Narendran S., Pereira F., Cummings T.H., Hardin J.W., Sutton S.S., Ambati J. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. Med. 2020;1(1):114\u2013127.", "ArticleIdList": ["PMC7274588", "32838355"]}, {"Citation": "Ludmir E.B., McCaw Z.R., Kim D.H., Tian L., Wei L.-J. Fulvestrant plus capivasertib for metastatic breast cancer. Lancet Oncol. 2020;21(5):233.", "ArticleIdList": ["32359498"]}, {"Citation": "Sun F., Mu C., Kwok H.F., Xu J., Wu Y., Liu W., Sabatier J.-M., Annweiler C., Li X., Cao Z. Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19. Int. J. Biol. Sci. 2021;17(9):2348\u20132355.", "ArticleIdList": ["PMC8241724", "34239361"]}, {"Citation": "Groneberg D.A., Poutanen S.M., Low D.E., Lode H., Welte T., Zabel P. Treatment and vaccines for severe acute respiratory syndrome. Lancet Infect. Dis. 2005;5(3):147\u2013155.", "ArticleIdList": ["PMC7106466", "15766649"]}, {"Citation": "Chan J.F.W., Yao Y., Yeung M.-L., Deng W., Bao L., Jia L., Li F., Xiao C., Gao H., Yu P. Treatment with lopinavir/ritonavir or interferon-\u03b21b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset. J. Infect. Dis. 2015;212(12):1904\u20131913.", "ArticleIdList": ["PMC7107395", "26198719"]}, {"Citation": "Lim J., Jeon S., Shin H.-Y., Kim M.J., Seong Y.M., Lee W.J., Choe K.-W., Kang Y.M., Lee B., Park S.J. Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J. Korean Med. Sci. 2020;35(6):79.", "ArticleIdList": ["PMC7025910", "32056407"]}, {"Citation": "Wang Z., Chen X., Lu Y., Chen F., Zhang W. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci. Trends. 2020;14:64\u201368.", "ArticleIdList": ["32037389"]}, {"Citation": "Young B.E., Ong S.W.X., Kalimuddin S., Low J.G., Tan S.Y., Loh J., Ng O.-T., Marimuthu K., Ang L.W., Mak T.M. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. Jama. 2020;323(15):1488\u20131494.", "ArticleIdList": ["PMC7054855", "32125362"]}, {"Citation": "Wu J.T., Leung K., Bushman M., Kishore N., Niehus R., de Salazar P.M., Cowling B.J., Lipsitch M., Leung G.M. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat. Med. 2020;26(4):506\u2013510.", "ArticleIdList": ["PMC7094929", "32284616"]}, {"Citation": "Florindo H.F., Kleiner R., Vaskovich-Koubi D., Ac\u00farcio R.C., Carreira B., Yeini E., Tiram G., Liubomirski Y., Satchi-Fainaro R. Immune-mediated approaches against COVID-19. Nat. Nanotechnol. 2020;15(8):630\u2013645.", "ArticleIdList": ["PMC7355525", "32661375"]}, {"Citation": "Rizk J.G., Kalantar-Zadeh K., Mehra M.R., Lavie C.J., Rizk Y., Forthal D.N. Pharmaco-immunomodulatory therapy in COVID-19. Drugs. 2020;80:1267\u20131292.", "ArticleIdList": ["PMC7372203", "32696108"]}, {"Citation": "Gbadamosi I.T. Stay safe: helpful herbal remedies in COVID-19 infection. Afr. J. Biomed. Res. 2020;23(2):131\u2013133."}, {"Citation": "Cheng Y., Wong R., Soo Y., Wong W., Lee C., Ng M., Chan P., Wong K., Leung C., Cheng G. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur. Eur. J. Clin. Microbiol. Infect. Dis. 2005;24(1):44\u201346.", "ArticleIdList": ["PMC7088355", "15616839"]}, {"Citation": "Yeh K.-M., Chiueh T.-S., Siu L., Lin J.-C., Chan P.K., Peng M.-Y., Wan H.-L., Chen J.-H., Hu B.-S., Perng C.-L. Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital. J. Antimicrob. Chemother. 2005;56(5):919\u2013922.", "ArticleIdList": ["PMC7110092", "16183666"]}, {"Citation": "Arabi Y.M., Hajeer A.H., Luke T., Raviprakash K., Balkhy H., Johani S., Al-Dawood A., Al-Qahtani S., Al-Omari A., Al-Hameed F. Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia. Emerg. Infect. Dis. 2016;22(9):1554\u20131561.", "ArticleIdList": ["PMC4994343", "27532807"]}, {"Citation": "Kraft C.S., Hewlett A.L., Koepsell S., Winkler A.M., Kratochvil C.J., Larson L., Varkey J.B., Mehta A.K., Lyon G.M., III, Friedman-Moraco R.J. The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States. Clin. Infect. Dis. 2015;61(4):496\u2013502.", "ArticleIdList": ["PMC4542597", "25904375"]}, {"Citation": "Stinebaugh B.J., Schloeder F.X., Johnson K.M., Mackenzie R.B., Entwisle G., De Alba E. Bolivian hemorrhagic fever: a report of four cases. Am. J. Med. 1966;40(2):217\u2013230.", "ArticleIdList": ["4159195"]}, {"Citation": "Kaku Y., Kuwata T., Zahid H.M., Hashiguchi T., Noda T., Kuramoto N., Biswas S., Matsumoto K., Shimizu M., Kawanami Y. Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19. Cell Rep. 2021;36", "ArticleIdList": ["PMC8226103", "34237284"]}, {"Citation": "Ruggiero H., Milani H., Barri A., Val A., Maglio F., Astarloa L., Milani H., Tallone J. Treatment of Argentine hemorrhagic fever with convalescent\u2019s plasma. 4433 cases. Presse Med. 1986;15(45):2239\u20132242.", "ArticleIdList": ["2949253"]}, {"Citation": "Shankar-Hari M., Estcourt L., Harvala H., Roberts D., Menon D.K. Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials. Crit. Care. 2020;24:449.", "ArticleIdList": ["PMC7370253", "32690059"]}, {"Citation": "Piechotta V., Iannizzi C., Chai K.L., Valk S.J., Kimber C., Dorando E., Monsef I., Wood E.M., Lamikanra A.A., Roberts D.J. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst. Rev. 2021;5 doi: 10.1002/14651858.CD013600.pub4.", "ArticleIdList": ["10.1002/14651858.CD013600.pub4", "PMC8135693", "34013969"]}, {"Citation": "Li L., Zhang W., Hu Y., Tong X., Zheng S., Yang J., Kong Y., Ren L., Wei Q., Mei H. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA. 2020;324(5):460\u2013470.", "ArticleIdList": ["PMC7270883", "32492084"]}, {"Citation": "Joyner M.J., Bruno K.A., Klassen S.A., Kunze K.L., Johnson P.W., Lesser E.R., Wiggins C.C., Senefeld J.W., Klompas A.M., Hodge D.O. Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients. Mayo Clin. Proc. 2020;95(9):1888\u20131897.", "ArticleIdList": ["PMC7368917", "32861333"]}, {"Citation": "Joyner M.J., Wright R.S., Fairweather D., Senefeld J.W., Bruno K.A., Klassen S.A., Carter R.E., Klompas A.M., Wiggins C.C., Shepherd J.R. Early safety indicators of COVID-19 convalescent plasma in 5000 patients. J. Clin. Investig. 2020;130(9):4791\u20134797.", "ArticleIdList": ["PMC7456238", "32525844"]}, {"Citation": "Hegerova L., Gooley T.A., Sweerus K.A., Maree C., Bailey N., Bailey M., Dunleavy V., Patel K., Alcorn K., Haley R. Use of convalescent plasma in hospitalized patients with COVID-19: case series. Blood. 2020;136(6):759\u2013762.", "ArticleIdList": ["PMC7414587", "32559767"]}, {"Citation": "Van Damme K.F., Tavernier S., Van Roy N., De Leeuw E., Declercq J., Bosteels C., Maes B., De Bruyne M., Bogaert D., Bosteels V. Case report: convalescent plasma, a targeted therapy for patients with CVID and severe COVID-19. Front. Immunol. 2020;11", "ArticleIdList": ["PMC7714937", "33329586"]}, {"Citation": "Moghaddam E., Teoh B.-T., Sam S.-S., Lani R., Hassandarvish P., Chik Z., Yueh A., Abubakar S., Zandi K. Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci. Rep. 2014;4(1):1\u20138.", "ArticleIdList": ["PMC4071309", "24965553"]}, {"Citation": "Khan Z., Karata\u015f Y., Ceylan A.F., Rahman H. COVID-19 and therapeutic drugs repurposing in hand: the need for collaborative efforts. Pharm. Hosp. Clin. 2020;56:3\u201311."}, {"Citation": "Fasogbon B.M., Ademuyiwa O.H., Bamidele O.P., Wahab I.E., Ola-Adedoyin A.T., Alakija O. Positive therapeutic role of selected foods and plant on ailments with a trend towards COVID-19: a review. Prev. Nutr. Food Sci. 2021;26(1):1\u201311.", "ArticleIdList": ["PMC8027051", "33859954"]}, {"Citation": "Olivieri F., Prasad V., Valbonesi P., Srivastava S., Ghosal-Chowdhury P., Barbieri L., Bolognesi A., Stirpe F. A systemic antiviral resistance-inducing protein isolated from Clerodendrum inerme Gaertn. is a polynucleotide: adenosine glycosidase (ribosome-inactivating protein) FEBS Lett. 1996;396(2\u20133):132\u2013134.", "ArticleIdList": ["8914973"]}, {"Citation": "Tsai Y.C., Lee C.-L., Yen H.-R., Chang Y.-S., Lin Y.-P., Huang S.-H., Lin C.-W. Antiviral action of tryptanthrin isolated from Strobilanthes cusia leaf against human coronavirus NL63. Biomolecules. 2020;10(3):366.", "ArticleIdList": ["PMC7175275", "32120929"]}, {"Citation": "Amber R., Adnan M., Tariq A., Mussarat S. A review on antiviral activity of the Himalayan medicinal plants traditionally used to treat bronchitis and related symptoms. J. Pharm. Pharmacol. 2017;69(2):109\u2013122.", "ArticleIdList": ["PMC7166987", "27905101"]}, {"Citation": "Gilani A.H., Khan Au, Raoof M., Ghayur M.N., Siddiqui B.S., Vohra W., Begum S. Gastrointestinal, selective airways and urinary bladder relaxant effects of Hyoscyamus niger are mediated through dual blockade of muscarinic receptors and Ca2+ channels. Fundam. Clin. Pharmacol. 2008;22(1):87\u201399.", "ArticleIdList": ["18251725"]}, {"Citation": "Khan M.Y., Kumar V. Mechanism & inhibition kinetics of bioassay-guided fractions of Indian medicinal plants and foods as ACE inhibitors. J. Tradit. Complement. Med. 2019;9(1):73\u201384.", "ArticleIdList": ["PMC6335474", "30671369"]}, {"Citation": "Khan R.I., Abbas M., Goraya K., Zafar-ul-Hye M., Danish S. Plant derived antiviral products for potential treatment of COVID-19: a review. Phyton. 2020;89(3):438\u2013452."}, {"Citation": "Verma V. Plant therapy of Corona Virus. Int. Pharm. Sci. 2020;10:102."}, {"Citation": "Centers for Disease Control and Prevention (CDC). Vaccines for COVID-19 (Accessed 17 July 2021). https://www.cdc.gov/coronavirus/2019-ncov/vaccines/."}, {"Citation": "Worldometers COVID-19. Coronavirus Pandemic Retrieved July 18 2021. https://www.worldometers.info/coronavirus/."}, {"Citation": "A.B. S.O.B. Kineret\u00ae(anakinra) injection, solution prescribing information, Stockholm Swed. Orphan Biovitrum AB 2018."}, {"Citation": "Kaly L., Rosner I. Tocilizumab\u2013a novel therapy for non-organ-specific autoimmune diseases. Best. Pract. Res. Clin. Rheumatol. 2012;26(1):157\u2013165.", "ArticleIdList": ["22424201"]}, {"Citation": "T.R. Tendinitis, O.M. Gravis, Highlights of prescribing information, These highlights do not include all the information needed to use LEVAQUIN\u00ae safely and effectively. See full prescribing information for LEVAQUIN\u00ae. LEVAQUIN\u00ae(levofloxacin) Tablet, Film Coated for Oral use."}, {"Citation": "Richardson P., Griffin I., Tucker C., Smith D., Oechsle O., Phelan A., Rawling M., Savory E., Stebbing J. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020;395(10223):30.", "ArticleIdList": ["PMC7137985", "32032529"]}, {"Citation": "Feldmann M., Maini R.N., Woody J.N., Holgate S.T., Winter G., Rowland M., Richards D., Hussell T. Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Lancet. 2020;395(10234):1407\u20131409.", "ArticleIdList": ["PMC7158940", "32278362"]}, {"Citation": "Herold S., Hoegner K., Vad\u00e1sz I., Gessler T., Wilhelm J., Mayer K., Morty R.E., Walmrath H.-D., Seeger W., Lohmeyer J. Inhaled granulocyte/macrophage colony\u2013stimulating factor as treatment of pneumonia-associated acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2014;189(5):609\u2013611.", "ArticleIdList": ["24579839"]}, {"Citation": "Shen C., Wang Z., Zhao F., Yang Y., Li J., Yuan J., Wang F., Li D., Yang M., Xing L. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. Jama. 2020;323(16):1582\u20131589.", "ArticleIdList": ["PMC7101507", "32219428"]}, {"Citation": "Stockman L.J., Bellamy R., Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006", "ArticleIdList": ["PMC1564166", "16968120"]}, {"Citation": "Villar J., Ferrando C., Martinez D., Ambros A., Munoz T., Soler J.A., Aguilar G., Alba F., Gonzalez-Higueras E., Conesa L.A. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir. Med. 2020;8(3):267\u2013276.", "ArticleIdList": ["32043986"]}, {"Citation": "Wang Y., Jiang W., He Q., Wang C., Wang B., Zhou P., Dong N., Tong Q. Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China. MedRxiv. 2020 doi: 10.1101/2020.03.06.20032342.", "ArticleIdList": ["10.1101/2020.03.06.20032342"]}, {"Citation": "Chen L., Shi M., Deng Q., Liu W., Li Q., Ye P., Yu X., Zhang B., Xu Y., Li X. A multi-center randomized prospective study on the treatment of infant bronchiolitis with interferon \u03b11b nebulization. PLoS One. 2020;15(2)", "ArticleIdList": ["PMC7034796", "32084142"]}, {"Citation": "Hung I.F.-N., Lung K.-C., Tso E.Y.-K., Liu R., Chung T.W.-H., Chu M.-Y., Ng Y.-Y., Lo J., Chan J., Tam A.R. Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020;395(10238):1695\u20131704.", "ArticleIdList": ["PMC7211500", "32401715"]}, {"Citation": "Dashti\u2010Khavidaki S., Khalili H. Considerations for statin therapy in patients with COVID\u201019. Pharmacotherapy. 2020;40(5):484\u2013486.", "ArticleIdList": ["PMC7262253", "32267560"]}, {"Citation": "Chang Y., Wei W. Angiotensin II in inflammation, immunity and rheumatoid arthritis. Clin. Exp. Immunol. 2015;179(2):137\u2013145.", "ArticleIdList": ["PMC4298392", "25302847"]}, {"Citation": "Ishaqui A.A., Khan A.H., Sulaiman S.A.S., Alsultan M.T., Khan I., Naqvi A.A. Assessment of efficacy of Oseltamivir-Azithromycin combination therapy in prevention of Influenza-A (H1N1) pdm09 infection complications and rapidity of symptoms relief. Expert Rev. Respir. Med. 2020;14(5):533\u2013541.", "ArticleIdList": ["32053044"]}, {"Citation": "Tang W., Cao Z., Han M., Wang Z., Chen J., Sun W., Wu Y., Xiao W., Liu S., Chen E. Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. BMJ. 2020;369:1849. doi: 10.1136/bmj.m1849.", "ArticleIdList": ["10.1136/bmj.m1849", "PMC7221473", "32409561"]}, {"Citation": "D. Hinton. Lett. revoking EUA chloroquine Phosphate hydroxychloroquine Sulfate 2020. https://www.raps.org/news-and-articles/news-articles/2020/6/fda-revokes-eua-for-hydroxychloroquine-chloroquine."}, {"Citation": "Gasparyan A.Y., Ayvazyan L., Yessirkepov M., Kitas G.D. Colchicine as an anti-inflammatory and cardioprotective agent. Expert Opin. Drug Metab. Toxicol. 2015;11(11):1781\u20131794.", "ArticleIdList": ["26239119"]}, {"Citation": "Ali A., Akhtar N., Khan B.A., Khan M.S., Rasul A., Khalid N., Waseem K., Mahmood T., Ali L. Acacia nilotica: a plant of multipurpose medicinal uses. J. Med. Plant Res. 2012;6(9):1492\u20131496."}, {"Citation": "Ahmed I., Aslam A., Mustafa G., Masood S., Ali M.A., Nawaz M. Anti-avian influenza virus H9N2 activity of aqueous extracts of Zingiber officinalis (Ginger) and Allium sativum (Garlic) in chick embryos. Pak. J. Pharm. Sci. 2017;30(4):1341\u20131344.", "ArticleIdList": ["29039335"]}, {"Citation": "Moradi M.-T., Karimi A., Fotouhi F., Kheiri S., Torabi A. In vitro and in vivo effects of Peganum harmala L. seeds extract against influenza A virus. Avicenna J. Phytomed. 2017;7(6):519\u2013530.", "ArticleIdList": ["PMC5745536", "29299435"]}, {"Citation": "Yang J.L., Ha T.K.Q., Oh W.K. Discovery of inhibitory materials against PEDV corona virus from medicinal plants. Jpn. J. Vet. Res. 2016;64:S53\u2013S63."}, {"Citation": "Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361(9374):2045\u20132046.", "ArticleIdList": ["PMC7112442", "12814717"]}, {"Citation": "Shin H.-B., Choi M.-S., Ryu B., Lee N.-R., Kim H.-I., Choi H.-E., Chang J., Lee K.-T., Jang D.S., Inn K.-S. Antiviral activity of carnosic acid against respiratory syncytial virus. Virol. J. 2013;10(1):1\u201311.", "ArticleIdList": ["PMC3852111", "24103432"]}, {"Citation": "Sood R., Swarup D., Bhatia S., Kulkarni D., Dey S., Saini M., Dubey S. Antiviral activity of crude extracts of Eugenia jambolana Lam. against highly pathogenic avian influenza (H5N1) virus. Indian J. Exp. Biol. 2012;50(3):179\u2013186.", "ArticleIdList": ["22439432"]}, {"Citation": "Zhang J., Zhan B., Yao X., Gao Y., Shong J. Antiviral activity of tannin from the pericarp of Punica granatum L. against genital Herpes virus in vitro. Zhongguo Zhong Yao Za Zhi. 1995;20(9):556\u2013558. 576.", "ArticleIdList": ["8679095"]}, {"Citation": "Escobar F.M., Sabini M.C., Zanon S.M., Tonn C.E., Sabini L.I. Antiviral effect and mode of action of methanolic extract of Verbascum thapsus L. on pseudorabies virus (strain RC/79) Nat. Prod. Res. 2012;26(17):1621\u20131625.", "ArticleIdList": ["21999656"]}, {"Citation": "Romeilah R.M., Fayed S.A., Mahmoud G.I. Chemical compositions, antiviral and antioxidant activities of seven essential oils. J. Appl. Sci. Res. 2010;6(1):50\u201362."}, {"Citation": "Choudhari M.K., Punekar S.A., Ranade R.V., Paknikar K.M. Antimicrobial activity of stingless bee (Trigona sp.) propolis used in the folk medicine of Western Maharashtra, India. J. Ethnopharmacol. 2012;141(1):363\u2013367.", "ArticleIdList": ["22425711"]}, {"Citation": "Guinot P., Lemoine A., Joos M.-\u00c9., P\u00e9legrin S., Gargadennec A., Rapior S., Poucheret P. Evaluation of antioxidant and antiproliferative activities of dyeing plants. Acta Bot. Gall. 2010;157(1):37\u201343."}, {"Citation": "Kothandan S., Swaminathan R. Evaluation of in vitro antiviral activity of Vitex negundo L., Hyptis suaveolens (L) poit., Decalepis hamiltonii Wight & Arn., to Chikungunya virus. Asian Pac. J. Trop. Dis. 2014;4:S111\u2013S115."}, {"Citation": "Moradi M.T., Karimi A., Rafieian-Kopaei M., Fotouhi F. In vitro antiviral effects of Peganum harmala seed extract and its total alkaloids against Influenza virus. Microb. Pathog. 2017;110:42\u201349.", "ArticleIdList": ["28629724"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "6", "Day": "13"}, {"Year": "2021", "Month": "7", "Day": "25"}, {"Year": "2021", "Month": "8", "Day": "3"}, {"Year": "2021", "Month": "8", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "13", "Hour": "20", "Minute": "16"}, {"Year": "2021", "Month": "8", "Day": "5"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34388532", "PMC8339548", "10.1016/j.biopha.2021.112015", "S0753-3322(21)00798-8"]}}], "PubmedBookArticle": []}